The Stanford Diabetes Research Center (SDRC) announced that it has received a major program grant from the National Institutes of Health (NIH). Stanford is only one of a handful of U.S. institutions to be supported as a NIH ‘Diabetes Research Center’. This is the first time Stanford has garnered this prestigious center designation
The SDRC is comprised of over 90 distinguished members from multiple schools at Stanford, including faculty in the Schools of Medicine, Engineering, and Arts and Sciences. These members are united by a common interest in understanding, treating and curing diabetes, including type 1 and type 2 diabetes, and forms of diabetes linked to pancreatic cancer. To support this work, the SDRC provides Research Cores, a Pilot and Feasibility Grant Program, Enrichment Activities, and other functions to support diabetes-related research at Stanford. The SDRC leadership includes its Director, Dr. Seung Kim, Professor of Developmental Biology and, by courtesy, of Medicine (Endocrinology and Oncology Divisions), and the SDRC Associate Director, Dr. David Maahs, Professor of Pediatrics, and Chief of the Division of Pediatric Endocrinology.
“Stanford has a superb group of investigators dedicated to transformative diabetes research, whose efforts are coordinated and aligned by the SDRC,” stated Kim. “We are thrilled to have earned this important support from the NIH to foster the SDRC programs. We also view this as important recognition of the outstanding and enduring fundamental and clinical investigations at Stanford that focus on understanding and treating diabetes and its complications. Unfortunately, diabetes incidence in its major forms is increasing worldwide. So this support is timely.”
The program project (P30) award for 7.7 million dollars from the NIDDK will provide support over the next five years for key functions of the SDRC.